Thanks for emailing that article!
Welcome. We hope our website will make it easy for you to find the information you need, and provide helpful answers to many of your questions about glaucoma.
The Glaucoma Research Foundation's mission is to cure glaucoma and restore vision through innovative research.
Since Dr. Robert Shaffer, a glaucoma specialist, started the Glaucoma Research Foundation (GRF) in 1978, our donors have contributed more than $60 million toward patient education and research to find a cure for glaucoma.
In recent years tremendous progress has been made toward understanding the causes and mechanisms of glaucoma. A ground-breaking study sponsored by GRF has helped ophthalmologists understand normal-tension glaucoma and the role of intraocular pressure in nerve damage.
Listen to an interview with Thomas M. Brunner:
2018 is the 17th year of a collaborative research program called Catalyst for a Cure. This innovative, multidisciplinary research program brings together scientists from different research institutions and specialties to address the root cause of glaucoma and accelerate the pace of discovery toward a cure.
In addition to Catalyst for a Cure, the Glaucoma Research Foundation funds research through our Shaffer Grants, individual grants awarded to scientists pursuing novel and promising ideas in the field of glaucoma research which otherwise might be overlooked or go unexplored.
We are proud of our comprehensive booklet, Understanding and Living with Glaucoma, and I encourage you to order a copy for yourself, or a relative or friend. In addition, there are more free informative articles and brochures available from the Foundation. Check out the rest of our web site to learn about our educational and research activities.
In 2011, Glaucoma Research Foundation launched Glaucoma 360, a series of three annual events uniting research, industry, and philanthropy with one mission — to find a cure for glaucoma. It begins with the Glaucoma 360 Annual Gala to benefit GRF and our mission to fund innovative research and provide education and support for glaucoma patients and their caregivers. Day 2 of Glaucoma 360 is our New Horizons Forum — a full day of presentations, panels and discussions with CEOs from start-up companies, industry executives, ophthalmic leaders, venture capitalists and the FDA. This unique gathering unites these catalysts dedicated to speeding the translation of new ideas to improved therapies for glaucoma patients. On day 3, the Glaucoma Symposia for clinicians highlight the latest advances in glaucoma management, medications and surgical technique.
If you have found our web site and information helpful, I hope you will consider a donation to help us continue our efforts. You can contribute online or send a check to support further education and research to find a cure.
Lastly, if you have questions or suggestions please call or send me an e-mail. I look forward to learning how we can be more effective in our efforts to help.
Thomas M. Brunner
President and CEO
Glaucoma Research Foundation